Background/Aims: RBFOX3, an RNA-binding fox protein, plays an important role in the differentiation of neuronal development, but its role in the chemosensitivity of hepatocellular carcinoma (HCC) to 5-FU is unknown. Methods: In this study, we examined the biological functions of RBFOX3 and its effect on the chemosensitivity of HCC cells to 5-FU in vitro and in a mouse xenograft model. Results: RBFOX3 was found to have elevated expression in HCC cell lines and tissue samples, and its knockdown inhibited HCC cell proliferation. Moreover, knockdown of RBFOX3 improved the inhibitory effect of 5-fluorouracil (5-FU) on cell proliferation, migration and invasion, and enhanced the apoptosis induced by 5-FU. However, overexpression of RBFOX3 reduced the inhibitory effect of 5-fluorouracil (5-FU) on cell proliferation, migration and invasion, and decreased the apoptosis induced by 5-FU. We further elucidated that RBFOX3 knockdown synergized with 5-FU to inhibit the growth and invasion of HCC cells through PI3K/AKT and epithelial-mesenchymal transition (EMT) signaling, and promote apoptosis by activating the cytochrome-c/caspase signaling pathway. Finally, we validated that RBFOX3 regulated 5-FU-mediated cytotoxicity in HCC in mouse xenograft models. Conclusions: The findings from this study indicate that RBFOX3 regulates the chemosensitivity of HCC to 5-FU in vitro and in vivo. Therefore, targeting RBFOX3 may
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Transient transfection of HCC cells
To inhibit RBFOX3 expression, cells were transfected with RBFOX3-specific siRNA oligonucleotide (100 nmol/L) 5'-GGC UAC ACG UCU CCA ACA UTT-3' (siRB-1) or 5'-GCG GCA AAU GUU CGG GCA AUU TT-3' (siRB-2), or the nonspecific siRNA 5'-UUC UCC GAA CGU GUC ACG UTT-3' (siNC). 48 hours post transfection, the interference effect was examined by western blot. The siRNAs were purchased from Shanghai GenePharma Co. (Shanghai, China).
Western blot analysis HCC cell lysates were prepared. Equal amounts of protein (30 µg) from each sample were resolved by 10% or 12% sodium dodecyl sulfate-polyacrylamide minigel (SDS-PAGE), electrophoretically transferred to a PVDF membrane, and the blots were probed with specific antibodies. The protein signals were visualized by an enhanced chemiluminescence reaction system as recommended by the manufacturer, and quantified using ImageQuant software. GAPDH served as the loading control.
Lentiviral Construction and Cell Transfection
The U6-sh-RBFOX3-EGFP-IRES-puromycin vectors were obtained from Genechem Company Ltd (Shanghai, China) to knock down RBFOX3. A lentiviral vector containing non-silencing short hairpin RNA was used as the negative control. HCC cells were infected with either the lentiviral vectors encoding RBFOX3-specific short hairpin RNA sequences or the negative control vector. Stable cell lines were selected using 1-2 µg/mL puromycin for 2 weeks. The efficiency of RNA interference was determined by western blot. All assays were independently performed in triplicates.
Cell viability assay Cells (2×10 2 cells per well) were seeded in 96-well plates and exposed to serial dilutions of 5-FU, siRNA or both for indicated time, and the viability of the cells was assessed by MTS assay (Promega, WI). Growth inhibition was presented as the percentage of surviving cells in treated versus control cells. The IC50 value was the concentration leading to 50% cell growth inhibition compared with untreated control. All assays were independently performed in triplicates.
Colony formation assay
Cells were plated in 6-well culture plates at 5×10 2 cells per well as single cells and treated with 5-FU, siRNA or both at the indicated concentrations. After incubation for another 14 days, cells were washed twice with phosphate buffered saline. Colonies were fixed with paraformaldehyde for 30 minutes and stained with crystal violet for 15 minutes. All assays were independently performed in triplicates.
Wound healing assay
Approximately 3×10 5 cells were plated in each well of a 6-well plate. After overnight incubation, cells were either untreated or treated with 5-FU, siRNA or both at the indicated concentrations. When cell confluence reached 90-100 % after treatment, wounds were made using a 200 μl pipette tip. The cells were rinsed several times with PBS to remove any free-floating cells and debris before growth medium was added back. Wound gap was observed and cells were photographed. All assays were independently performed in triplicates.
Transwell invasion assay
Matrigel invasion assays were performed using a 24-well cell culture insert and BD Matrigel (BD Biocoat, Bedford, MA). The transwell membrane was coated with 30 μL diluted Matrigel. After overnight incubation, 5×10 4 cells suspended in 200 μL medium without FBS were added to the upper chamber with matrix gel, whereas 500 μL medium with 30% FBS was added to the lower chamber. After 24 hours, the cells that had not migrated through the pores were manually removed from the upper face of the filters with cotton swabs, and the cells adhered to the bottom surface of the inserts were fixed in paraformaldehyde and stained with crystal violet. Finally, the filters were washed thoroughly in water and images were taken under a microscope with appropriate magnification. All assays were independently performed in triplicates.
Apoptosis analysis
Apoptosis in HCC cells untreated or treated with 5-FU, siRNA or both was measured by AnnexinV and propidium iodide (KeyGEN, Nanjing, China) staining based fluorescence-activated cell sorting (FACS ) infected with either the lentiviral vectors encoding specific short hairpin RNA sequences (shRB) or the negative control vector (shNC) suspended in 100 μL cold PBS were inoculated subcutaneously into the flank of the nude mice. Once palpable tumors had developed, the mice were treated with PBS or 5-FU, 20 mg/kg twice per week. Tumor volumes and body weight were recorded every three days. The tumor volume was calculated as: Volume =π× Length × Width × High / 6. All mice were sacrificed 3 weeks after the injection, and the tumors were excised for weight and volume measurement. For the lung metastatic model, approximately 1×10
6 Hep3B cells in 100 μL PBS were injected into the tail veins of the nude mice. Three days later, the mice were treated with PBS or 5-FU, 20 mg/ kg twice per week. All mice were sacrificed 8 weeks after the injection, and the lungs were harvested. The metastatic nodules in each lung were counted. The tumors were excised from sacrificed mice, embedded in paraffin and sectioned.
Confocal immunofluorescence
For confocal microscopy analysis, cells grown on chamber slides were washed with PBS, fixed with paraformaldehyde and permeabilized with pre-cooled methyl alcohol for 15 min at -20°C. The samples were then pretreated with 10% bovine serum albumin (BSA) in PBS for 30 min, and specific antibodies were added and incubated overnight at 4°C. Following five 5 min washes with PBS, secondary antibodies were added and incubated for another hour. After five additional 5 min washes, samples were examined using the confocal microscope.
Immunohistochemistry staining
Mouse xenograft tumor tissues were analyzed by IHC staining. Briefly, after deparaffinizing, blocking and antigen retrieval, the tumor sections were incubated with primary antibodies at 4°C overnight in a humidified chamber. After washing, tumor sections were incubated with horseradish peroxidase-conjugated anti-goat antibodies for 30 min at room temperature, and colors were developed with 3, 5-diaminobenzidine (DAB) substrate followed by Mayer's hematoxylin counterstaining.
In situ TUNEL assay
To observe the apoptotic cells in tumor tissues, in situ TUNEL (Keygen Bio-Technology Development Co., Ltd. Nanjing, China) assay was performed on the pathological sections. Briefly, the sections were prepared and deparaffinized in xylene, hydrated through graded alcohols and water, and treated with protease K. Terminal deoxynucleotidyl transferase (TdT) and dUTP-biotin were added and incubated for 1 hour at 37°C. After washing with PBS, the sections were incubated with streptavidin-HRP and developed with DAB for 10 min.
Statistical analysis
Results are presented as mean±SE of at least three independent experiments. Differences between the mean values of the two subgroups were evaluated using Student's t-test. As for comparison among more than two groups, one-way ANOVA were used. P < 0.05 was considered to be statistically significant in this study. SPSS 13.0 software was used for all statistical analysis.
Results
RBFOX3 knockdown suppressed HCC cell growth
To explore the potential function of RBFOX3 in hepatocellular carcinoma, we first evaluated the expression of RBFOX3 in HCC cell lines. We found that the expression of Cellular Physiology and Biochemistry Cellular Physiology and Biochemistry RBFOX3 was higher in human HCC cells (SNU-449, Hep3B, Bel-7402, SNU-387, and HepG2) than in human immortalized hepatic cell line (MIHA) at the protein levels, and Hep3B and HepG2 had higher RBFOX3 expression than the other three HCC cells (Fig. 1A) . We next analyzed the expression of RBFOX3 in seven pairs of HCC and paratumor tissues, and found that the protein level of RBFOX3 was significantly higher in HCC tissues than the adjacent non-tumor liver tissues (Fig. 1B) . To further examine the biological effects of RBFOX3 on HCC cell growth, we knocked down RBFOX3 and analyzed cell viability by MTS assay and colony formation assay. The results showed that RBFOX3 knockdown (si-RB-1 and si-RB-2) caused dramatic inhibition of cell proliferation (Fig. 1C ) and colony formation (Fig. 1D ) in HCC cells by comparison with the non-specific siRNA control (si-NC). Moreover, we found that cells in the control group had filopodia and formed a cell layer, whereas RBFOX3 knockdown markedly reduced cell-to-cell contact and filopodia formation (Fig. 1C) .
RBFOX3 regulated the sensitivity of HCC to 5-FU through inhibiting the PI3K and AKT pathway 5-FU is a frequently used chemotherapeutic drug for the treatment of HCC. However, its dosage is limited by its detrimental side effects. We reasoned that RBFOX3 knockdown might enhance the sensitivity of HCC cells to 5-FU. To test this hypothesis, we first established HepG2 and Hep3B stable cell lines encoding RBFOX3-specific short hairpin RNA sequences (shRB-1 and shRB-2) or the negative control (shNC). We found that the density of RBFOX3-knockdown cells treated with 5-FU was significantly decreased compared to the control treated with 5-FU alone in both Hep3B and HepG2 cells ( Fig. 2A) . We also found that 5-FU inhibited cell viability and colony formation in dose dependent manners, and its inhibitory effect on RBFOX3-knockdown cells was stronger than the control cells ( (Fig. 2B, right panel) . Furthermore, we found that 5-FU inhibited cell viability in time dependent manners, and its inhibitory effect on RBFOX3-knockdown cells was stronger than the control cells (Fig. 2C) . We also found its inhibitory effect on RBFOX3-knockdown cells was stronger than the control cells in colony formation (Fig. 2F) . However, the inhibitory effect of 5-FU on RBFOX3 overexpressing cells was weaker than the control cells in cell viability and colony formation ( Fig. 2D and 2G ). This indicated that RBFOX3 could regulate the sensitivity of HCC cells to 5-FU.
To elucidate the molecular mechanisms by which RBFOX3 regulated the sensitivity of HCC cells to 5-FU, we analyzed the effect of 5-FU and RBFOX3 on the pivotal proteins in the PI3K/AKT pathway, a crucial pathway associated with tumorigenesis of various human cancers. The results showed that 5-FU alone increased the phosphorylation of PI3K, AKT, and ERK proteins in a dose dependent manner in both Hep3B and HepG2 cells. However, RBFOX3 knockdown in both Hep3B and HepG2 cells dramatically suppressed the phosphorylation of PI3K, AKT, and ERK proteins, and the suppression persisted in the presence of 5-FU (Fig. 2H) . Therefore, RBFOX3 knockdown suppressed PI3K-AKT signal activated by 5-FU, resulting in the reduced effective concentration of 5-FU. Our study above suggested that RBFOX3 regulated the sensitivity of HCC cells to 5-FU through the PI3K/AKT pathway.
RBFOX3 regulated 5-FU-induced apoptosis through the cytochrome-c/caspase signaling pathway
Apoptosis is a process of programmed cell death which also influenced cell viability, and most anticancer drugs function primarily to induce apoptosis. We hypothesized that RBFOX3 knockdown potentiated the cytotoxicity of 5-FU via the apoptosis signaling pathway. To test this hypothesis, we measured apoptosis of HCC cells by flow cytometry. As is showed in Fig. 3A , RBFOX3 knockdown potentiated 5-FU-induced apoptosis compared to 5-FU treatment alone. Inversely, we found that overexpression of RBFOX3 decreased the number of apoptotic cells induced by 5-FU in Hep3B and HepG2 cells (Fig. 3B) . enhanced in RBFOX3-knockdown cells. We next detected by western blot the downstream key pro-apoptotic proteins of the caspase cascade-dependent apoptotic signaling pathway such as caspase-3, caspase-9, and PARP. We found that 5-FU increased the levels of the cleaved pro-apoptotic proteins, and RBFOX3 knockdown combined with 5-FU further elevated the levels of cleaved PARP, cleaved caspase-3 and cleaved caspase-9 (Fig. 3D) . Thus, these results indicated that RBFOX3 regulated the 5-FU-induced apoptosis through the cytochrome-c/ caspase signaling pathway.
RBFOX3 regulated 5-FU-mediated inhibition of cell migration and invasion through epithelial-mesenchymal transition (EMT) in HCC cells
Distant metastasis is a common cause of HCC related death, and as a result, agents inhibiting metastasis are potential drugs for cancer treatment. To investigate whether RBFOX3 knockdown combined with 5-FU exerted synergistic inhibition on cell migration and invasion, we performed wound healing assay and transwell invasion assay. As is showed in Fig. 4A , RBFOX3 knockdown combined with 5-FU inhibited cell migration more significantly than 5-FU alone. However, the inhibition of migration mediated by 5-FU was reversed by RBFOX3 overexpression (Fig. 4B) . Transwell invasion assay also showed RBFOX3 knockdown combined with 5-FU inhibited cell invasion more significantly than 5-FU alone (Fig. 4C) , and the inhibition of invasion mediated by 5-FU could be reversed by RBFOX3 overexpression (Fig. 4D) . Moreover, as epithelial-to-mesenchymal transition (EMT) is crucial for metastasis, we examined the cytoskeleton by IF assay and the expression of proteins related to EMT (N-cadherin, snail and vimentin) by western blot. The results showed that the number of spike-like flopodia at the edges of the cells treated with 5-FU was decreased, and the decrease was more prominent in RBFOX3 cells treated with 5-FU (Fig. 4C) . Also, the expressions of the EMT related proteins N-cadherin, snail and vimentin were downregulated while E-cadherin was up-regulated in cells treated by 5-FU, which were more significant in RBFOX3-knockdown cells (Fig. 4D) . N-cadherin is a cell adhesion molecule that regulates cell-cell adhesion and modulates cell migration during EMT [19] , while vimentin is potentially a predictor of EMT behavior [20] . In addition, snail is a transcription factor that represses E-cadherin and mediates EMT [21] [22] [23] , whereas downregulation of E-cadherin is associated with EMT during embryonic development, a process also exploited by invasive cancer cells [24] . Therefore, these results indicated that RBFOX3 regulated 5-FU-mediated inhibition of cell migration and invasion through EMT in HCC cells.
RBFOX3 regulated 5-FU-mediated inhibition of HCC growth and metastasis in vivo
To investigate whether RBFOX3 regulated 5-FU-mediated HCC growth in vivo, we utilized a mouse subcutaneous xenograft model. Fifteen BALB/c nude mice were randomly assigned into three groups and inoculated in the flank with Hep3B cells (3×10 6 /mouse) with RBFOX3-specific or control shRNA. The RBFOX3-knockdown group and one control group received 5-FU treatment for three weeks (20 mg/kg, twice per week), while the other control group received PBS. As is shown in Fig. 5A , the tumor volume and tumor weight were decreased in the group treated with 5-FU alone when compared to the PBS control group, and were further decreased in the RBFOX3-knockdown combined with 5-FU treatment group. We next analyzed the effect of RBFOX3 knockdown and 5-FU on apoptosis in tumor tissues by TUNEL assay. As is shown in Fig. 5B , the level of apoptosis in the control group was negligible, whereas it became significant in the 5-FU treated group, and even more prominent in the RBFOX3-knockdown with 5-FU treatment group. To further investigate whether RBFOX3 regulated 5-FU-mediated inhibition of tumor metastasis in vivo, the lung metastatic model was established. We found that treatment of 5-FU decreased the number of metastatic nodules compared with the control group, and the number of metastatic nodules was further decreased in the RBFOX3-knockdown with 5-FU treatment group (Fig. 5C ). Immunohistochemical staining of the excised tumor sections further revealed that consistent with the in vitro results, RBFOX3 knockdown suppressed the elevation of p-PI3K and p-AKT caused by 5-FU, and the expression of N-cadherin, snail and vimentin were significantly Cellular Physiology and Biochemistry
Cellular Physiology and Biochemistry
decreased while E-cadherin was significantly increased in the RBFOX3-knockdown with 5-FU treatment group when compared with the group treated with 5-FU alone (Fig. 5D ). These data further indicate that RBFOX3 knockdown synergized with 5-FU to regulate HCC tumor growth, EMT and apoptosis in vivo.
Discussion
Over the past decade, HCC is one of the few cancers that have a rise in incidence. Though the treatment of HCC has made some progress, much more effort is needed to improve the treatment effect. As a pyrimidine analog, 5-FU is used extensively for the clinical treatment of various types of solid tumors, including breast [25] , colorectal [26] , HCC [27] , stomach and gullet cancers [28] . However, 5-FU resistance is a malignant phenotype, and its dosage was limited because of its side effects including gastrointestinal reaction and palmar plantar erythroderma [29] . Therefore, it is necessary to find new therapeutic targets that can synergize with 5-FU in cancer treatment.
The RNA-binding protein RBFOX3 is a well-known splicing regulator used as a marker for post-mitotic neurons in various vertebrate species. Recent genetic studies have implicated that RBFOX3 is involved in numerous neurological dysfunctions in humans, such as the development of autistic features, epilepsy, cognitive impairments, and neurodevelopmental delay. Although previous studies reported RBFOX3 was exclusively expressed in post-mitotic neurons of the central nervous system, recent studies indicated that RBFOX3 is also expressed in some non-neuronal tissues [30, 31] . Another study showed that RBFOX3 expression was inhibited during TGF-β-induced epithelial-mesenchymal transition (EMT) in lung cancer [32] . Nevertheless, the cellular function of RBFOX3 in tumorigenesis remains unclear. Here, we report that RBFOX3 was highly expressed in HCC cell lines and tissues, and RBFOX3 knockdown inhibited HCC cell growth and colony formation. What's more, the sensitivity of HCC cells to 5-FU was enhanced with RBFOX3 knockdown, as 5-FU had a stronger growth inhibition effect on the RBFOX3-knockdown cells than the control cells. We further found that RBFOX3 knockdown enhanced the growth inhibition by 5-FU through targeting the PI3K/AKT pathway. As one of the most important pathways participating in cells growth, the PI3K/AKT pathway is generally inactivated with treatment of most anticancer drugs. However, chemotherapy-induced activation of cell survival pathways has been observed [33] , which may lead to drug resistance. For example, drugs like paclitaxel, pemetrexed, and docetaxel have been reported to activate cell survival pathways such as PI3K/AKT or EGFR pathway [34] [35] [36] . Consistent with the results from esophageal squamous cell carcinoma cells exposed to 5-FU [37] , our study also found that 5-FU inhibited HCC cell growth with increased phosphorylation of PI3K, AKT and ERK proteins, indicating that 5-FU suppressed cell growth via other pathways. Since activation of the PI3K/AKT pathway may partly offset the inhibition of cell growth, combinatorial treatment with 5-FU and another agent that inactivates the PI3K/AKT pathway will improve the anticancer effect of 5-FU. Consistently, our study demonstrated that RBFOX3 knockdown synergized with 5-FU by inactivating the PI3K/AKT pathway.
We also tried to identify other potential mechanisms by which RBFOX3 knockdown increased the sensitivity to 5-FU of HCC cells. As most anticancer drugs function primarily to induce apoptosis [38] , and emerging data have indicated that 5-FU alone could induce apoptosis in gastric [39] , colorectal [40] and thymic cells [41] , we examined whether RBFOX3 knockdown increased 5-FU-induced apoptosis. Our results showed that RBFOX3 knockdown increased the levels of cleaved PARP, caspase-3 and caspase-9 in HCC cells, and synergized with 5-FU in inducing apoptosis by increasing the release of cytochrome-c and the levels of the cleaved pro-apoptotic proteins, indicating that RBFOX3 knockdown enhanced 5-FUinduced apoptosis by activating the cytochrome-c/caspase signaling pathway.
The prognosis of HCC patients remains unsatisfactory due to a high incidence of metastasis, which contributes to around 90% of cancer-related mortality [42, 43] . Therefore, Cellular Physiology and Biochemistry
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it is necessary to identify prognostic markers and treatment targets for metastatic HCC. Results from wound healing and transwell invasion assay suggested that RBFOX3 knockdown combined with 5-FU inhibited cell migration and invasion more significantly than treatment with 5-FU alone. As epithelial-mesenchyme transition (EMT) is known to be a central mechanism responsible for invasiveness and metastasis of various cancers [44] , and previous studies reported that RBFOX3 and 5-FU were involved in EMT [45，46], we explored whether RBFOX3 knockdown enhanced 5-FU-mediated inhibition of cell migration and invasion through EMT. We found fewer spike-like flopodia, a characteristic of invasive cancer cells, in RBFOX3-knockdown cells treated with 5-FU than the 5-FU-treated control cells. Consistently, EMT related proteins N-cadherin, snail and vimentin were further down-regulated with E-cadherin further up-regulated in RBFOX3-knockdown cells treated with 5-FU compared with control cells treated with 5-FU alone. Based on these findings, we believe that RBFOX3 knockdown enhanced 5-FU-mediated inhibition of cell migration and invasion through inhibiting EMT.
Conclusion
Taken together, findings from the present study indicate that RBFOX3 regulated 5-FUmediated cytotoxicity via the PI3K/AKT, EMT and cytochrome-c/caspase pathway in HCC both in vitro and in vivo (Fig. 6 ).
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